Výsledky vyhledávání - Helena Marzo‐Ortega

Upřesnit hledání
  1. 1
    Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis

    Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis Autor Helena Marzo‐Ortega

    Vydáno 2002
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study

    Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study Autor Helena Marzo‐Ortega

    Vydáno 2005
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice

    New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice Autor Sayam Dubash, Dennis McGonagle, Helena Marzo‐Ortega

    Vydáno 2017
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond

    The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond Autor Sayam Dubash, Charlie Bridgewood, Dennis McGonagle, Helena Marzo‐Ortega

    Vydáno 2018
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  5. 5
    The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science

    The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science Autor ‬‬‬‬Abdulla Watad, Charlie Bridgewood, Tobias Russell, Helena Marzo‐Ortega, Richard Cuthbert, Dennis McGonagle

    Vydáno 2018
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades

    Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades Autor Samantha S. R. Crossfield, Helena Marzo‐Ortega, Sarah R. Kingsbury, Mar Pujades-Rodriguez, Philip G. Conaghan

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    The problem in differentiation between psoriatic-related polyenthesitis and fibromyalgia

    The problem in differentiation between psoriatic-related polyenthesitis and fibromyalgia Autor Antonio Marchesoni, Gabriele De Marco, Mira Merashli, Frank McKenna, Ilaria Tinazzi, Helena Marzo‐Ortega, Dennis McGonagle

    Vydáno 2017
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis

    Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis Autor Laura C. Coates, Lorna Cawkwell, Nora Ng, Alexander N. Bennett, Domini Bryer, Alexander Fraser, Paul Emery, Helena Marzo‐Ortega

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2

    Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2 Autor Helena Marzo‐Ortega, Joachim Sieper, Alan Kivitz, Ricardo Blanco, Martin Cohen, Evie-Maria Delicha, Susanne Rohrer, Hanno B. Richards

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol

    Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol Autor Mark Quinn, Michael J. Green, Helena Marzo‐Ortega, Susanna Proudman, Zunaid Karim, Richard J. Wakefield, Philip G. Conaghan, Paul Emery

    Vydáno 2003
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study

    Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study Autor Helena Marzo‐Ortega, Joachim Sieper, Alan Kivitz, Ricardo Blanco, Maxime C. Cohen, Roland Martinꝉ, Aimee Readie, H. Richards, Brian Porter

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis

    Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis Autor Dafna D. Gladman, Ana‐Maria Orbai, Uta Klitz, James Cheng‐Chung Wei, Gaia Gallo, Julie Birt, Suchitrita S. Rathmann, David Shrom, Helena Marzo‐Ortega

    Vydáno 2019
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis

    Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis Autor Martín Rudwaleit, James T. Rosenbaum, Robert Landewé, Helena Marzo‐Ortega, Joachim Sieper, D. van der Heijde, O. Davies, Holger Bartz, Bengt Hoepken, T. Nurminen, Atul Deodhar

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    OP0250 Can rankl serum levels predict future progression to rheumatoid arthritis in acpa negative patients?

    OP0250 Can rankl serum levels predict future progression to rheumatoid arthritis in acpa negative patients? Autor Agata Burska, Jehan J. El‐Jawhari, Ai Lyn Tan, R. J. Wakefield, Helena Marzo‐Ortega, Philip G. Conaghan, Paul Emery, Frédérique Ponchel, Jane Freeston

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis

    A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management... Autor Zoe Ash, C. Gaujoux-Viala, Laure Gossec, E. Hensor, Oliver FitzGerald, Kevin Winthrop, Désirée van der Heijde, Paul Emery, Josef S Smolen, Helena Marzo‐Ortega

    Vydáno 2011
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis

    Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis Autor Richard Cuthbert, Evangelos M. Fragkakis, Robert Dunsmuir, Zhi Li, Mark Coles, Helena Marzo‐Ortega, Peter V. Giannoudis, Elena Jones, Yasser M. El‐Sherbiny, Dennis McGonagle

    Vydáno 2017
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation

    Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation Autor Mark Corbett, Marta Soares, Gurleen Jhuti, Stephen Rice, Eldon Spackman, E.G. Sideris, Thirimon Moe‐Byrne, Dave Fox, Helena Marzo‐Ortega, Lesley Kay, Nerys Woolacott, Stephen Palmer

    Vydáno 2016
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression

    Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression Autor Richard Cuthbert, ‬‬‬‬Abdulla Watad, Evangelos M. Fragkakis, Robert Dunsmuir, Peter Loughenbury, Almas Khan, Peter Millner, Adam Davison, Helena Marzo‐Ortega, Darren J. Newton, Charlie Bridgewood, Dennis McGonagle

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

    Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies Autor Atul Deodhar, C. Miceli-Richard, Xenofon Baraliakos, Helena Marzo‐Ortega, Dafna D. Gladman, Ricardo Blanco, Ayan Das Gupta, Ruvie Martin, Jorge Safi, Brian Porter, Abhijit Shete, James T. Rosenbaum

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    <scp>Poly‐Refractory</scp> Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes

    <scp>Poly‐Refractory</scp> Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes Autor Paula David, Andrea Di Matteo, Or Hen, Shouvik Dass, Helena Marzo‐Ortega, Richard J. Wakefield, Leslie‐Anne Bissell, Jacqueline Nam, Kulveer Mankia, Paul Emery, Benazir Saleem, Dennis McGonagle

    Vydáno 2023
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: